🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested
The primary objective of this study is to assess the safety and tolerabilit...
Status
Completed
Location
Pacific Oncololgy & Hematology
Start Date
2009-06
Trial ID
NCT00920855
Treatments Being Tested
Eligible participants with newly diagnosed myeloma who are not considered e...
Status
Recruiting
Location
Gundersen Lutheran
Start Date
2026-09
Trial ID
NCT07285239
The purpose of this study is to improve efficacy of treatment for patients ...
Status
Completed
Location
Mannheimer Onkologie Praxis
Start Date
2014-11
Trial ID
NCT02237261
Treatments Being Tested
This study is researching a drug called linvoseltamab (also called "study d...
Status
Recruiting
Location
Emory Winship Cancer Institute
Start Date
2026-01-02
Trial ID
NCT07222761
Treatments Being Tested
This phase II trial studies how well tacrolimus, bortezomib, and anti-thymo...
Status
Terminated
Location
Emory University/Winship Cancer Institute
Start Date
2016-09
Trial ID
NCT02877082
Treatments Being Tested
The purpose of the study is to identify specific genes that are up- or down...
Status
Unknown
Location
Department of Haematology, Aalborg University Hospital
Start Date
2014-01
Trial ID
NCT02109861
Treatments Being Tested
Leukemia cells grow and divide fast and out of control. In normal cells, ce...
Status
Terminated
Location
St. Jude Children's Research Hospital
Start Date
2018-04-20
Trial ID
NCT03515200
This is an open label, dose escalation, phase I study of the combination of...
Status
Withdrawn
Location
Dartmouth-Hitchcock Medical Center
Start Date
2016-08
Trial ID
NCT03422874
Treatments Being Tested
RATIONALE: Bortezomib may stop the growth of cancer cells by blocking some ...
Status
Unknown
Location
Alta Bates Summit Comprehensive Cancer Center
Start Date
2006-08
Trial ID
NCT00438841
Treatments Being Tested